IMO the only realistic non dilutive funding in the next 6 months outside of a tax credit is a grant for ELTO 2b lets stay realistic...after that small-moderate revenues in 3/4th quarter from Lympro probably in line with Jasons prediction of 1 million for 2015. 2016/17 will be the "monumental year(s)" Gerald is just doing his job.